People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Infinity Bio, Inc. | — | Biotechnology | Series A | $11.5M | $16.6M | 2025 |
Herman M Scholtz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Herman M Scholtz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Caroline Popper | 1 | 5 |
| Malek Benjamin Fahem | 1 | 1 |
| H. Benjamin Larman | 1 | 1 |
| Herman Benjamin Scholtz | 1 | 1 |
| Matthew Benjamin Hellauer | 1 | 1 |
| Joy Nassif | 1 | 1 |
| Matthew Hellauer | 1 | 1 |
| Benjamin Larman | 1 | 1 |
| Joy M Nassif | 1 | 1 |
| Bill Benjamin Campbell | 1 | 1 |
| Herman Scholtz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.